Hepatitis C in hemodialysis patients: Current global magnitude, natural history, diagnostic difficulties, and preventive measures

American Journal of Nephrology

Volumn 28, Issue 4, 2008, Pages 628-640

  Rahnavardi, Mohammad ^a   Hosseini Moghaddam, Seyed Mohammadmehdi ^a,c   Alavian, Seyed Moayed ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology, HCV; Hemodialysis; Hepatitis C virus, prevalence; Natural history, HCV; Nosocomial transmission, HCV; Prevention, HCV; Renal failure, diagnosis

Indexed keywords

BLOOD TRANSFUSION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE CONTROL; EPIDEMIOLOGICAL DATA; FALSE NEGATIVE RESULT; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; MORBIDITY; MORTALITY; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRUS ISOLATION; VIRUS TRANSMISSION;

CROSS INFECTION; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS;

EID: 45149094507     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117573     Document Type: Review

References (157)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
2. Yen T, Keeffe EB, Ahmed A: The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003;36:47-53.
3. Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171.
4. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.
5. Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
6. Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, Millian SJ: Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet 1974;2:241-246.
7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
8. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shini T, Simmonds P, Smith D, Stuyver L, Weiner A: Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 1998;143:2493-2503.
9. Pawlotsky JM: Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 2003;7:45-66.
10. Wreghitt TG: Blood-borne virus infections in dialysis units - a review. Rev Med Virol 1999;9:101-109.
11. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkodi S, Goubau P, HCV Collaborative Group: The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004;19:904-909.
12. Gallego E, Lopez A, Perez J, Llamas F, Lorenzo I, Lopez E, Illescas ML, Andres E, Olivas E, Gomez-Roldan C: Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract 2006;104:c1-c6.
13. Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, Lampe E, Yoshida CF, Martins RM: Decline of hepatitis C infection in hemodialysis patients in Central Brazil: ten years of surveillance. Mem Inst Oswaldo Cruz 2005;100:345-349.
14. Yang CS, Chang HH, Chou CC, Peng SJ: Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. J Formos Med Assoc 2003;102:79-85.
15. Barril G, Traver JA: Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Res 2003;60:129-134.
16. Shamshirsaz AA, Kamgar M, Bekheirnia MR, Ayazi F, Hashemi SR, Bouzari N, Habibzadeh MR, Pourzahedgilani N, Broumand V, Shamshirsaz AH, Moradi M, Borghei M, Haghighi NN, Broumand B: The role of hemodialysis machines dedication in reducing hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 2004;5:13.
17. Saxena AK, Panhotra BR, Sundaram DS, Naguib M, Venkateshappa CK, Uzzaman W, Mulhim KA: Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east. Am J Infect Control 2003;31:26-33.
18. Valtuille R, Moretto H, Lef L, Rendo P, Fernandez JL: Decline of high hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up. Clin Nephrol 2002;57:371-375.
19. Aucella F, Vigilante M, Valente GL, Stallone C: Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis. Blood Purif 2000;18:110-114.
20. Buturovic-Ponikvar J, Expert Group for Dialysis in Slovenia at the Ministry of Health, Republic of Slovenia: Renal replacement therapy in Slovenia: annual report 2001. Nephrol Dial Transplant 2003;18(suppl 5):v53-v55.
21. Omar MN, Tashkandy MA: Liver enzyme and protein electrophoretic pattern in hemodialysis patients with antibodies against the hepatitis C virus. Saudi Med J 2003;2:S122.
22. Almawi WY, Qadi AA, Tamim H, Ameen G, Bu-Ali A, Arrayid S, Abou Jaoude MM: Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Transplant Proc 2004;36:1824-1826.
23. Reddy AK, Dakshinamurty KV, Lakshmi V: Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol 2006;24:55-57.
24. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM: Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran - a multicenter study. J Med Virol 2006;78:569-573.
25. Amiri ZM, Shakib AJ, Toorchi M: Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. East Mediterr Health J 2005;11:372-376.
26. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S: Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton) 2003;8:256-260.
27. Ansar MM, Kooloobandi A: Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 2002;9:390-392.
28. Kumagai J, Komiya Y, Tanaka J, Katayama K, Tatsukawa Y, Yorioka N, Miyakawa Y, Yoshizawa H: Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003. J Med Virol 2005;76:498-502.
29. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003;14:3270-3277.
30. Furusyo N, Hayashi J, Kakuda K, Ariyama I, Kanamoto-Tanaka Y, Shimizu C, Etoh Y, Shigematsu M, Kashiwagi S: Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study. Am J Gastroenterol 2001;96:1592-1600.
31. Iwasaki Y, Esumi M, Hosokawa N, Yanai M, Kawano K: Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection. J Hosp Infect 2000;45:54-61.
32. Bdour S: Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol 2002;51:700-704.
33. Gul A, Iqbal F: Prevalence of hepatitis C in patients on maintenance haemodialysis. J Coll Physicians Surg Pak 2003;13:15-18.
34. Hussein MM, Mooij JM, Hegazy MS, Bamaga MS: The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Saudi J Kidney Dis Transpl 2007;18:107-113.
35. Shaheen FA, Huraib SO, Al-Rashed R, Al-Drees A, Arif M, Al-Jeffry M, Tashkandy MA, Safwat M: Prevalence of hepatitis C antibodies among hemodialysis patients in Jeddah area, Saudi Arabia. Saudi Med J 2003;2:S125-S126.
36. Saxena AK, Panhotra BR: The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly 2003;133:611-618.
37. Al-Shohaib SS, Abd-Elaal MA, Zawawi TH, Abbas FM, Shaheen FA, Amoah E: The prevalence of hepatitis C virus antibodies among hemodialysis patients in Jeddah area, Saudi Arabia. Saudi Med J 2003;2:S125.
38. Othman B, Monem F: Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 2001;29:262-265.
39. Ocak S, Duran N, Kaya H, Emir I: Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. Int J Clin Pract 2006;60:670-674.
40. Olut AI, Ozsakarya F, Dilek M: Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey. J Int Med Res 2005;33:641-646.
41. Harmankaya O, Cetin B, Obek A, Seber E: Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Ren Fail 2002;24:639-644.
42. Ahmetagic S, Muminhodzic K, Cickusic E, Stojic V, Petrovic J, Tihic N: Hepatitis C infection in risk groups. Bosn J Basic Med Sci 2006;6:13-17.
43. Salama G, Rostaing L, Sandres K, Izopet J: Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol 2000;61:44-51.
44. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE: Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002;51:429-433.
45. Rigopoulou EI, Stefanidis I, Liaskos C, Zervou EK, Rizos C, Mina P, Zachou K, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Dalekos GN: HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece. J Clin Virol 2005;34:81-85.
46. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A: Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005;45:334-343.
47. Garinis G, Spanakis N, Theodorou V, Gorgoulis V, Manolis E, Karameris A, Valis D: Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients. J Clin Lab Anal 1999;13:122-125.
48. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001;37:1004-1010.
49. Campo N, Brizzolara R, Sinelli N, Torre F, Russo R, Deferrari G, Picciotto A: TT virus infection in haemodialysis patients. Nephrol Dial Transplant 2000;15:1823-1826.
50. Lombardi M, Cerrai T, Geatti S, Negroni S, Pertusini L, Pegoraro M, Di Lullo G: Results of a national epidemiological investigation on HCV infection among dialysis patients. (Survey by the Italian Branch of EDTNA/ERCA). J Nephrol 1999;12:322-327.
51. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M: Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999;14:40-45.
52. Schneeberger PM, Keur I, van Loon AM, Mortier D, de Coul KO, van Haperen AV, Sanna R, van Der Heijden TG, van Den Hoven H, van Hamersvelt HW, Quint W, van Doorn LJ: The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis 2000;182:1291-1299.
53. Lopez-Alcorocho JM, Barril G, Ortiz-Movilla N, Traver JA, Bartolome J, Sanz P, Selgas R, Carreno V: Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol 2001;63:103-107.
54. Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A: Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Intern Med 2002;251:119-128.
55. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S: Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 2007;18:1584-1593.
56. Kalantar-Zadeh K, Miller LG, Daar ES: Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 2005;46:290-300.
57. Kelley VA, Everett-Kitchens J, Brannon LE, Connor K, Martinez EJ, Pearson TC, Nolte FS: Lack of seronegative hepatitis C virus infections in patients with chronic renal failure. Transplantation 2002;74:1473-1475.
58. Sivapalasingam S, Malak SF, Sullivan JF, Lorch J, Sepkowitz KA: High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect Control Hosp Epidemiol 2002;23:319-324.
59. Sullivan DG, Kim SS, Wilson JJ, Stehman-Breen C, Gretch DR: Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis. J Virol Methods 2001;96:5-16.
60. Saab S, Martin P, Brezina M, Gitnick G, Yee HF Jr: Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Am J Kidney Dis 2001;37:308-315.
61. Otedo AE, Mc'Ligeyo SO, Okoth FA, Kayima JK: Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J 2003;93:380-384.
62. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM: Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J 2002;23:1356-1360.
63. Diouf ML, Diouf B, Niang A, Ka EH, Pouye A, Seck A, Raphenon G, Moreira-Diop T: Prevalence of hepatitis B and C viruses in a chronic hemodialysis center in Dakar. Dakar Med 2000;45:1-4.
64. El-Amin HH, Osman EM, Mekki MO, Abdelraheem MB, Ismail MO, Yousif ME, Abass AM, El-haj HS, Ammar HK: Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report. Saudi J Kidney Dis Transpl 2007;18:101-106.
65. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, Ben Redjeb S, Izopet J: Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol 2006;78:185-191.
66. Bouzgarrou N, Fodha I, Othman SB, Achour A, Grattard F, Trabelsi A, Pozzetto B: Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol 2005;77:502-508.
67. Ben Othman S, Bouzgarrou N, Achour A, Bourlet T, Pozzetto B, Trabelsi A: High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia. Pathol Biol (Paris) 2004;52:323-327.
68. Ayed K, Gorgi Y, Ben Abdallah T, Aouadi H, Jendoubi-Ayed S, Sfar I, Makni H: Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods. Transplant Proc 2003;35:2573-2575.
69. Santos MA, Souto FJ: Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study. BMC Public Health 2007;7:32.
70. Silva LK, Silva MB, Rodart IF, Lopes GB, Costa FQ, Melo ME, Gusmao E, Reis MG: Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res 2006;39:595-602.
71. Albuquerque AC, Coelho MR, Lopes EP, Lemos MF, Moreira RC: Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem Inst Oswaldo Cruz 2005;100:467-470.
72. Moreira R, Pinho JR, Fares J, Oba IT, Cardoso MR, Saraceni CP, Granato C: Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol 2003;49:503-507.
73. Carneiro MA, Martins RM, Teles SA, Silva SA, Lopes CL, Cardoso DD, Vanderborght BO, Yoshida CF: Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz 2001;96:765-769.
74. Carvalho M, Branco PB, Luvizotto ML, Valderrama DE, Rabone S, Doi E, Ivantes C, Muzzillo DA: High Prevalence of hepatitis C virus infection in chronic hemodialysis patients. Braz J Infect Dis 1999;3:144-148.
75. Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M: Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiarycare hospital in Mexico City, Mexico. J Clin Microbiol 2004;42:4321-4322.
76. Sanchez JL, Sjogren MH, Callahan JD, Watts DM, Lucas C, Abdel-Hamid M, Constantine NT, Hyams KC, Hinostroza S, Figueroa-Barrios R, Cuthie JC: Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. Am J Trop Med Hyg 2000;63:242-248.
77. Lopez-Navedo PJ, Lebron-Rivera R, Gonzalez-Trapaga J, Weber-Acevedo J, Lefevre-Ramos E, Flores-de Hostos E, Jaume-Anselmi F, Ramirez-Rivera J: Prevalence of hepatitis C virus infection at three hemodialysis units in the western region of Puerto Rico. Bol Asoc Med PR 1999;91:100-102.
78. Alter MJ: Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-2441.
79. Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L: Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005;77:70-76.
80. Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P: De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther 2005;21:861-869.
81. Fabrizi F, Martin P, Dixit V, Brezina M, Russell J, Conrad A, Schmid P, Gerosa S, Gitnick G: Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol 1999;19:383-388.
82. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65:2335-2342.
83. Stramer SL: Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007;131:702-707.
84. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC: Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007;47:316-325.
85. Saxena AK, Panhotra BR: The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc 2004;52:242-246.
86. McHutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, Nelles M, Polito A, Chien D, DiNello R, et al: Improved detection of hepatitis C virus antibodies in high risk populations. Hepatology 1992;15:19-25.
87. Chaudhary RK, Andonov A, MacLean C: Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction. J Clin Lab Anal 1993;7:164-167.
88. Alter MJ, Kuhnert WL, Finelli L, Centers for Disease Control and Prevention: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52:1-13.
89. Saab S, Brezina M, Gitnick G, Martin P, Yee HF Jr: Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 2001;38:91-97.
90. Neng Lai K: Hepatitis C infection screening in hemodialysis units. Am J Kidney Dis 2001;38:186-188.
91. Scott JD, Gretch DR: Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 2007;297:724-732.
92. Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998;47:1-39.
93. Centers for Disease Control and Prevention: Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50:1-43.
94. Natov SN, Pereira BJ: Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients. Semin Dial 2000;13:393-398.
95. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F: Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001;38:1009-1015.
96. Goicoechea M, Martin J, de Sequera P, Quiroga JA, Ortiz A, Carreño V, Caramelo C: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 1998;54:1337-1343.
97. Martín J, de Sequera P, Quiroga JA, Rico M, Fernández M, Arocena C, Caramelo C, Carreño V: Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine 2000;12:1248-1252.
98. Pertosa G, Grandaliano G, Gesualdo L, Schena FP: Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 2000;58:S104-S111.
99. Rico MA, Ruiz S, Subira D, Barril G, Cigarran S, Castanon S, Quiroga JA, Selgas R, Carreno V: Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection. J Med Virol 2004;72:66-74.
100. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, Guntaka RV: High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 2006;6:198-204.
101. Hadlich E, Alvares-Da-Silva MR, Molin RK, Zenker R, Goldani LZ: Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies detectable by third-generation enzyme immunoassay. J Gastroenterol Hepatol 2007;22:1506-1509.
102. Courouce AM, Le Marrec N, Bouchardeau F, Razer A, Maniez M, Laperche S, Simon N: Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000;40:1198-1202.
103. Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, Vigilante D, Limido A, Martin P: Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 2005;43:414-420.
104. Aoyagi K, Iida K, Ohue C, Matsunaga Y, Tanaka E, Kiyosawa K, Yagi S: Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection. Clin Lab 2001;47:119-127.
105. Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G: Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000;69:1479-1484.
106. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML: Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999;94:3576-3582.
107. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, Jensik S, Jensen DM: Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002;35:191-195.
108. Sezer S, Ozdemir BH, Arat Z, Turan M, Ozdemir NF, Haberal M: Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients. Ren Fail 2001;23:807-818.
109. Boyacioglu S, Gur G, Yilmaz U, Korkmaz M, Demirhan B, Bilezikci B, Ozdemir N: Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus. Transplant Proc 2004;36:50-52.
110. Furusyo N, Hayashi J, Kanamoto-Tanaka Y, Ariyama I, Etoh Y, Shigematsu M, Kashiwagi S: Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study. Dig Dis Sci 2000;45:2221-2228.
111. al-Wakeel J, Malik GH, al-Mohaya S, Mitwalli A, Baroudi F, el Gamal H, Kechrid M: Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1996;11:2265-2268.
112. Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, Herion D, Park Y, Liang TJ, Hoofnagle JH: Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003;124:97-104.
113. Mathurin P, Mouqet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29:257-263.
114. Rao KV, Anderson WR, Kasiske BL, Dahl DC: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993;94:241-250.
115. Ahmad A, Hasan F, Abdeen S, Sheikh M, Kodaj J, Nampoory MR, Johny KV, Asker H, Siddique I, Thalib L, Al-Nakib B: Transjugular liver biopsy in patients with end-stage renal disease. J Vasc Interv Radiol 2004;15:257-260.
116. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: an update. Am J Kidney Dis 2003;42:631-657.
117. Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A: Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 1999;56:2286-2291.
118. Akpolat I, Ozyilkan E, Karagoz F, Akpolat T, Kandemir B: Hepatitis C in haemodialysis and nonuraemic patients: a histopathological study. Int Urol Nephrol 1998;30:349-355.
119. Luzar B, Ferlan-Marolt V, Brinovec V, Lesnicar G, Klopcic U, Poljak M: Does endstage kidney failure influence hepatitis C progression in hemodialysis patients? Hepatogastroenterology 2003;50:157-160.
120. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1998;80:428-433.
121. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G: Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis 2003;42:143-150.
122. Lemos LB, Perez RM, Lemos MM, Lanzoni VP, Draibe SA, Silva IS, Silva AE, Ferraz ML: Hepatitis C in chronic kidney disease: predialysis patients present more severe histological liver injury than hemodialysis patients? Am J Nephrol 2007;27:191-196.
123. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-1902.
124. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 2004;20:1271-1277.
125. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Aljama P: Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 2001;16:1669-1674.
126. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998;32:629-634.
127. Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998;53:1374-1381.
128. Savas N, Ocal S, Colak T, Karakayali H, Yilmaz U, Haberal M: Clinical course of hepatitis C virus infection in renal transplant recipients. Transplant Proc 2007;39:984-986.
129. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, Okuyama A, Shinji Y, Nagano S: Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66:471-476.
130. Mahmoud IM, Elhabashi AF, Elsawy E, El-Husseini AA, Sheha GE, Sobh MA. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 2004;43:131-139.
131. Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY, Chang FY, Lee SD: Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Zhonghua Yi Xue Za Zhi (Taipei) 2000;63:93-100.
132. Breitenfeldt MK, Rasenack J, Berthold H, Olschewski M, Schroff J, Strey C, Grotz WH: Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002;16:130-136.
133. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM: Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 2003;18:836-840.
134. Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR: Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc 2005;37:3045-3047.
135. Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M: Renal transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant 2004;18:619-623.
136. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, Al Adbha B, Hammad D: Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract 2006;102:c72-c80.
137. Magnone M, Holley JL, Shapiro R, Scantlebury V, McCauley J, Jordan M, Vivas C, Starzl T, Johnson JP: Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995;59:1068-1070.
138. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D: Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995;59:1426-1431.
139. Kamar N, Ribes D, Izopet J, Rostaing L: Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation 2006;82:853-856.
140. Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L: Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003;14:2092-2098.
141. Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr: Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003;98:1610-1615.
142. Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P: Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003;18:1071-1081.
143. Kondili LA, Genovese D, Argentini C, Chionne P, Toscani P, Fabro R, Cocconi R, Rapicetta M: Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center. Eur J Clin Microbiol Infect Dis 2006;25:527-531.
144. Halfon P, Roubicek C, Gerolami V, Quentin Y, Khiri H, Pepe G, Berland Y: Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J Clin Microbiol 2002;40:1541-1545.
145. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO: Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 2001;65:517-524.
146. Hosokawa N, Esumi M, Iwasaki Y, Yanai M, Enomoto A, Kawano K: Phylogenetic evidence, by multiple clone analysis of hypervariable region 1, for the transmission of hepatitis C virus to chronic haemodialysis patients. J Viral Hepat 2000;7:276-282.
147. Katsoulidou A, Paraskevis D, Kalapothaki V, Arvanitis D, Karayiannis P, Hadjiconstantiou V, Hatzakis A: Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999;14:1188-1194.
148. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L: Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999;58:139-144.
149. Savey A, Simon F, Izopet J, Lepoutre A, Fabry J, Desenclos JC: A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol 2005;26:752-760.
150. Delarocque-Astagneau E, Baffoy N, Thiers V, Simon N, de Valk H, Laperche S, Courouce AM, Astagneau P, Buisson C, Desenclos JC: Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine? Infect Control Hosp Epidemiol 2002;23:328-334.
151. Jadoul M: Epidemiology and mechanisms of transmission of the hepatitis C virus in haemodialysis. Nephrol Dial Transplant 2000;15:39-41.
152. Jadoul M, Cornu C, van Ypersele de Strihou C: Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 1998;53:1022-1025.
153. Saxena AK, Panhotra BR: The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit. Med Princ Pract 2004;13:129-135.
154. Alfurayh O, Sabeel A, Al Ahdal MN, Almeshari K, Kessie G, Hamid M, Dela Cruz DM: Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 2000;20:103-106.
155. Taskapan H, Oymak O, Dogukan A, Utas C: Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001;55:477-481.
156. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL: Prevention of hepatitis C virus in dialysis units. Nephron 1995;70:301-306.
157. Froio N, Nicastri E, Comandini UV, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N: Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 2003;42:546-550.